Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to 13590.48%.

  • Envoy Medical's EBIT Margin fell 47119000.0% to 13590.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 9824.04%, marking a year-over-year decrease of 21150500.0%. This contributed to the annual value of 8558.22% for FY2024, which is 27484100.0% down from last year.
  • As of Q3 2025, Envoy Medical's EBIT Margin stood at 13590.48%, which was down 47119000.0% from 6500.0% recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's EBIT Margin registered a high of 3150.88% during Q3 2022, and its lowest value of 14530.0% during Q4 2022.
  • Its 4-year average for EBIT Margin is 8250.01%, with a median of 7135.29% in 2024.
  • As far as peak fluctuations go, Envoy Medical's EBIT Margin soared by 74531600bps in 2023, and later plummeted by -47119000bps in 2025.
  • Quarter analysis of 4 years shows Envoy Medical's EBIT Margin stood at 14530.0% in 2022, then soared by 51bps to 7076.84% in 2023, then tumbled by -53bps to 10830.95% in 2024, then decreased by -25bps to 13590.48% in 2025.
  • Its EBIT Margin was 13590.48% in Q3 2025, compared to 6500.0% in Q2 2025 and 11102.17% in Q1 2025.